1. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol rev. 2006; 28(1): 112-25.
2. Horvat RT. Diagnostic and clinical relevance of HBV mutations. Lab Med. 2011; 42(8): 488-96.
3. Abdolsamadi H, Vaziri PB, Abdollahzadeh S, Kashani KM, Vahedi M. Immune response to Hepatitis B vaccine among dental students. Iran J Public Health. 2009; 38(2): 113-8.
4. Miguel J, Coquette A, Bresson-Hadni S. [The other types of viral hepatitis]. La Revue du praticien. 1990; 40(18): 1656-9.
5. Kaplowitz N. Drug-induced liver injury. Clin Infect Dis. 2004; 38(Suppl 2): S44-8.
6. Koff RS. Vaccines and Hepatitis B. Clin Liver Dis. 1999; 3(2): 417-28.
7. Zajac B, West D, McAleer W, Scolnick E. Overview of clinical studies with Hepatitis B vaccine made by recombinant DNA. J Infect. 1986; 13: 39-45.
8. Villeneuve JP, Condreay LD, Willems B, Pomier‐Layrargues G, Fenyves D, Bilodeau M, et al. Lamivudine treatment for decompensated cirrhosis resulting from chronic Hepatitis B. Hepat. 2000; 31(1): 207-10.
9. Foy MC, Thio CL, Hwang HS, Saulynas M, Hamilton JP, Fine DM, et al. False-negative Hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States. Clin Vaccine Immunol. 2012; 19(5): 820-2.
10. Ferreira CT, Silveira TRd. Viral hepatitis prevention by immunization. J Pediatr (Rio J). 2006; 82(3): s55-s66.
11. Chakraborty B, Bashar T, Roy K, Noor R, Rahman MM. Persistence of anti-HBs antibody and immunological memory in healthy individuals vaccinated with Hepatitis B vaccine. Stamford J Microbiol. 2011; 1(1): 37-41.
12. Mansour GF, Fallah M, Jafarshad R, Joukar F, Arami M, Ale-Esmaeil A, et al. The Immunologic Response to anti-hepatitis B vaccination among medical students of Guilan University of Medical Sciences, Guilan. Iran Hepat Mon. 2006; 6(2): 63-66.
13. Taheri H, Hasanjani Roushan MR, Soleimani Amiri MJ, Pouralijan M,Bijani A. Efficacy of Hepatitis B vaccine in those who lost Hepatitis B surface antigen during follow-up. Hepat Mon. 2011; 11(2): 119-122.
14. Zuckerman JN, Sabin C, Fiona MC, Williams A, Zuckerman AJ. Immune response to a new Hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study. BMJ. 1997; 314(7077): 329-33.
15. Marocho L, Vildozola H, Valencia E, Romero G, Huaman A, Solano L, et al. [Comparative study on the protective effect of two immunization schemes using a Hepatitis B recombinant vaccine in vulnerable health science students]. Rev Gastroenterol Peru. 2004; 25(4): 313-319.
16. Mozes E, McDevitt HO, Jaton J-C, Sela M. The nature of the antigenic determinant in a genetic control of the antibody response. J Exp Med. 1969; 130(3): 493-504.
17. Varla‐Laftnerioti M, Papanicolaou M, Spyropoulou M, Vallindra H, Tsiroyianni P, Tassopoulos N, et al. HLA‐associated non‐responsiveness to Hepatitis B vaccine. Tissue Antigens. 1990; 35(2): 60-3.
18. Milich D, Chisari F. Genetic regulation of the immune response to Hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg. J Immunol. 1982; 129(1): 320-5.
19. Milich DR, Leroux-Roels GG, Louie RE. Genetic regulation of the immune response to Hepatitis B surface antigen (HBsAg). J Exp Med. 1984; 159: 41-56.
20. Vranckx R, Muylle L, Cole J, Moldenhaser R, Peetermans M. HBV vaccinations in medical and paramedical staff: the impact of age on immunization results. Vox Sang. 1986; 50(4): 220-2.
21. Janbakhsh A, Mansouri F, Vaziri S, Sayad B, Afsharian M, Rahimi M, et al. Effect of selenium on immune response against Hepatitis B vaccine with accelerated method in insulin-dependent diabetes mellitus patients. Caspian J Int Med. 2013; 4(1): 603-6.
22. Perera J, Perera B, Gamage S. Seroconversion after Hepatitis B vaccination in healthy young adults, and the effect of a booster dose. Ceylon Med J. 2014; 47(1): 6-8.
23. Alavian SM, Mahboobi N, Mahboobi N. Anti-HBs antibody status and some of its associated factors in dental health care workers in Tehran University of Medical Sciences: Anti-HBs Ab and associated factors in dental society. Hepat Mon. 2011; 11(2): 99-102.
24. Parker DC. T cell-dependent B cell activation. Annu Rev Immunol. 1993; 11(1): 331-60.
25. Jee SH, Ohrr H, Sull JW, Samet JM. Cigarette smoking, alcohol drinking, Hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst. 2004; 96(24): 1851-6.
26. Chopra S, Tupper J, Ahn C, Bayog R, Koff R, editors. Hepatitis-B markers in an alcohol treatment unit. Gastroenterology; 1980: WB Saunders Co Independence Square West Curtis Center, Ste 300, Philadelphia, PA 19106-3399.
27. Vargas V, Pedreira JD, Esteban R, Hernández JM, Guardia J, Bacardi R. Hepatitis B virus infection in alcoholic cirrhosis. Br Med J (Clin ResEd). 1981; 282(6277): 1705-6.
28. Rosman AS, Basu P, Galvin K, Lieber CS. Efficacy of a high and accelerated dose of Hepatitis B vaccine in alcoholic patients: A randomized clinical trialfn1fn1.This research was supported by DHHS Grant AA-07275, the department of veterans affairs, the Kingsbridge Research Foundation, and SmithKline Beecham Pharmaceuticals. Am J Med. 1997; 103(3): 217-22.